Predictors of sustained viral suppression among children living with HIV in Kenya: Secondary analysis of data from a randomized control study
Clicks: 1
ID: 314751
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #29 of 40 articles by views in journal of the pediatric infectious diseases society
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background Viral suppression (VS) amongst children living with HIV (CLHIV) remains poor and several factors may affect sustained VS (SVS) over time. Methods We conducted a secondary analysis of data from a randomized control trial among CLHIV in western Kenya assessing individual, caregiver, and household factors associated with SVS, defined as viral load <1000 copies/ml throughout the study period of 12 months. We used multivariate logistic regression analysis, adjusting for additional covariates. Results A total of 668 CLHIV were included, median age of 9 years (interquartile range (IQR) 7-12) and time on ART 6 years (IQR 3-8). Using a VL cut off of 1000 copies/ml, the factors associated with lower odds of SVS were: (1) self-reported child’s poor ART adherence [adjusted odds ratio (AOR) 0.43; 95% confidence interval (CI): (0.27, 0.69)]; (2) being on protease inhibitor-containing regimen [AOR 0.49 (0.31, 0.79)]; (3) spending less than 30 minutes travelling to the facility [AOR 0.59 (0.37, 0.95)] and (4) having more VL results available for analysis [AOR 0.80 (0.71, 0.90)]. At VL cut off of 200 copies/ml and 50 copies/ml, being on PI containing regimen and travel duration to clinic were no longer associated with SVS. However, at VL cut off of 50 copies/ml, additional factors associated with lower odds of SVS were less than 2 years on ART [AOR 0.29 (0.14, 0.64)] and caregiver depression [AOR 0.61 (0.41, 0.91)]. Conclusion This analysis found that adherence on ART, years on ART, ART “anchor” drug, caregiver depression, travel duration to the health facility and number of VL assays were associated with SVS among CLHIV. Interventions to improve health outcomes for CLHIV should consider and address all relevant risk factors for viral non-suppression. Clinical Trial Number: NCT03820323
| Reference Key |
openalex_W7162209270
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Patrick Oyaro, Garoma Wakjira Basha, Katherine K. Thomas, Evelyn Brown, Shukri A. Hassan, Rabbia Imran, Enericah Karauki, Nashon Yongo, Pooja Maheria, Rena C Patel, Lisa Abuogi |
| Journal | journal of the pediatric infectious diseases society |
| Year | 2026 |
| DOI |
10.1093/jpids/piag038
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.